These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7905867)

  • 21. Binding to delta and mu opioid receptors by deltorphin I/II analogues modified at the Phe3 and Asp4/Glu4 side chains: a report of 32 new analogues and a QSAR study.
    Schullery SE; Mohammedshah T; Makhlouf H; Marks EL; Wilenkin BS; Escobar S; Mousigian C; Heyl DL
    Bioorg Med Chem; 1997 Dec; 5(12):2221-34. PubMed ID: 9459020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
    Shenderovich MD; Nikiforovich GV; Golbraikh AA
    Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid peptides. Synthesis and binding assays of desamino-Tyr1 dermorphin analogues. XII.
    Salvadori S; Marastoni M; Balboni G; Tomatis R; Borea PA
    Farmaco Sci; 1987 Dec; 42(12):931-40. PubMed ID: 2896601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues.
    Lazarus LH; Salvadori S; Tomatis R; Wilson WE
    Biochem Biophys Res Commun; 1991 Jul; 178(1):110-5. PubMed ID: 1648906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity.
    Schiller PW; Nguyen TM; Chung NN; Lemieux C
    J Med Chem; 1989 Mar; 32(3):698-703. PubMed ID: 2537427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
    Heyl DL; Mosberg HI
    Int J Pept Protein Res; 1992 May; 39(5):450-7. PubMed ID: 1330964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6.
    Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R
    J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
    Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
    J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
    Ambo A; Niizuma H; Sasaki A; Kohara H; Sasaki Y
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1269-72. PubMed ID: 12657261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
    Negri L; Lattanzi R; Melchiorri P
    Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid receptor binding profile of selected dermorphin-like peptides.
    Rossi AC; de Castiglione R; Perseo G
    Peptides; 1986; 7(5):755-9. PubMed ID: 2879276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential contribution of C-terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency.
    Sagan S; Amiche M; Delfour A; Camus A; Mor A; Nicolas P
    Biochem Biophys Res Commun; 1989 Sep; 163(2):726-32. PubMed ID: 2551274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor-induced internalization of selective peptidic mu and delta opioid ligands.
    Gaudriault G; Nouel D; Dal Farra C; Beaudet A; Vincent JP
    J Biol Chem; 1997 Jan; 272(5):2880-8. PubMed ID: 9006932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships of dermorphin synthetic analogues.
    de Castiglione R; Rossi AC
    Peptides; 1985; 6 Suppl 3():117-25. PubMed ID: 3831955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin.
    Strack M; Bedini A; Yip KT; Lombardi S; Siegmund D; Stoll R; Spampinato SM; Metzler-Nolte N
    Chemistry; 2016 Oct; 22(41):14605-10. PubMed ID: 27553294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.